Delivery of apoptotic signal to rolling cancer cells: A novel biomimetic technique using immobilized TRAIL and E‐selectin
暂无分享,去创建一个
[1] F. Orr,et al. Tumor cell interactions with the microvasculature: a rate-limiting step in metastasis. , 2001, Surgical oncology clinics of North America.
[2] C. Rauch,et al. Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.
[3] A. Evdokiou,et al. Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy , 2003, British Journal of Cancer.
[4] R. Khokha,et al. Steps in tumor metastasis: new concepts from intravital videomicroscopy , 1995, Cancer and Metastasis Reviews.
[5] M. Nau,et al. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. , 2001, Gynecologic oncology.
[6] I. Macdonald,et al. Cancer spread and micrometastasis development: Quantitative approaches for in vivo models , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[7] M. Clarke,et al. Identification of pancreatic cancer stem cells. , 2007, Cancer research.
[8] D. Nance,et al. Interactions between cancer cells and the endothelium in metastasis , 2000, The Journal of pathology.
[9] G. Naumov,et al. Molecular biology of breast cancer metastasis: Clinical implications of experimental studies on metastatic inefficiency , 2000, Breast Cancer Research.
[10] S. Strom,et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.
[11] C. Pona,et al. Effectiveness of Leukocyte Filters in Reducing Tumor Cell Contamination after Intraoperative Blood Salvage in Lung Cancer Patients , 1997, Vox sanguinis.
[12] R. Waugh,et al. Thermoelasticity of red blood cell membrane. , 1979, Biophysical journal.
[13] I. Bechmann,et al. Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) , 2000, The Lancet.
[14] J. Jelinek,et al. TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors , 2002, Leukemia.
[15] E. McCulloch,et al. Mouse myeloma tumor stem cells: a primary cell culture assay. , 1971, Journal of the National Cancer Institute.
[16] A. Varki,et al. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. , 1999, The American journal of pathology.
[17] N. Mitsiades,et al. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. , 2001, Cancer research.
[18] J. Fricker. On the TRAIL to a new cancer therapy. , 1999, Molecular medicine today.
[19] D. Hammer,et al. Lu‐ECAM‐1‐mediated adhesion of melanoma cells to endothelium under conditions of flow , 1996, International journal of cancer.
[20] B. Bonavida,et al. A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance. , 2002, Advances in cancer research.
[21] G. Naumov,et al. Critical steps in hematogenous metastasis: an overview. , 2001, Surgical oncology clinics of North America.
[22] L. Andĕra,et al. Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo , 2007, British Journal of Cancer.
[23] E. Alnemri,et al. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. , 2000, Blood.
[24] D. Gilliland,et al. Leukaemia stem cells and the evolution of cancer-stem-cell research , 2005, Nature Reviews Cancer.
[25] M. Nau,et al. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. , 1999, Cancer research.
[26] K. Schulze-Osthoff,et al. Potential and caveats of TRAIL in cancer therapy. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[27] R. Yu,et al. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells. , 2000, Cancer research.
[28] T. Miki,et al. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin. , 2001, The Journal of urology.
[29] A. Ashkenazi,et al. Targeting death and decoy receptors of the tumour-necrosis factor superfamily , 2002, Nature Reviews Cancer.
[30] Y. Gazitt. TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells , 1999, Leukemia.
[31] J. Liesveld,et al. Investigating the Feasibility of Stem Cell Enrichment Mediated by Immobilized Selectins , 2007, Biotechnology progress.
[32] Xunbin Wei,et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment , 2005, Nature.
[33] M. L. Blair,et al. Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device , 2008, British journal of haematology.
[34] K. Oldhafer,et al. Filtration of malignant cells: tumour cell depletion in an ex vivo model using a leukocyte adhesion filter , 2001, Perfusion.
[35] I. Sarelius,et al. Preferential Binding of Leukocytes to the Endothelial Junction Region in Venules In Situ , 2005, Microcirculation.
[36] A. Belldegrun,et al. Actinomycin D and Gemcitabine Synergistically Sensitize Androgen-Independent Prostate Cancer Cells to Apo2L/TRAIL-Mediated Apoptosis , 2001, Journal of immunotherapy.
[37] D. Lawrence,et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. , 1999, The Journal of clinical investigation.
[38] M. Edelman,et al. The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. , 1996, Urology.
[39] J. Liesveld,et al. P-Selectin coated microtube for enrichment of CD34+ hematopoietic stem and progenitor cells from human bone marrow. , 2008, Clinical chemistry.
[40] E. Bröcker,et al. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. , 2000, Cancer research.